web analytics
0.3 C
Munich
Saturday, December 3, 2022

The Latest on US Lithium Corp (OTCMKTS: LITH) (BioELife)

US Lithium Corp (OTCMKTS: LITH) has emerged as one of the top most traded stocks in small caps in recent weeks. From illiquid at $0.25 the stock has transformed into a volume leader regularly topping $500k in dollar volume as the stock recently topped $1.50 per share.

The move on LITH comes as the Company makes a noisy move into the booming CBD space with the acquisition of four cannabinoid related business. LITH has not been quiet about the size of the new market they are entering noting in their “about us” section in recent press releases “The Company is uniquely positioned to capitalize on the emerging Cannabinoid market that is growing at phenomenal rates and is expected to reach $20 Billion over the next five years.

US Lithium Corp (OTCMKTS: LITH) says its new strategic direction as BioELife was created by successful pharmaceutical entrepreneurs dedicated to using nature’s resources to fight pain and infection while reducing the dependency on opioids and their terrible side effects. The Company is uniquely positioned to capitalize on the emerging Cannabinoid market that is growing at phenomenal rates and is expected to reach $20 Billion over the next five years. The Company has created a ‘seed to shelf’ value-added product development and marketing organization with direct contracts for raw materials, scientific formulation, manufacturing, and distribution of medically focused Cannabinoid products. In order to better reflect this new strategic direction, the Company is in the process of changing its name and symbol to BioELife which should be effective within the next thirty days.

The Company announced their official entry into CBD on January 21 with the acquisition of four cannabinoid related contracts between Hemp Cloud 9 and four unrelated parties in exchange for 4.7M shares of LITH stock. Several days later the bod approved an amendment changing the name of the corporation from U.S. Lithium Corp. to BioELife Corp. The name change which will take effect in the next 30 days will better reflect the Company’s new strategic focus on the rapidly growing CBD market.

To Find out the inside Scoop on LITH Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

LITH

Since then the new CBD Company has put out a flurry of press: On February 12 LITH announced it has completed production and began shipping its latest pain cream, ChiroRub 2000. The proprietary formulation, containing 2,000 mg of CBD, has been doctor and patient tested and is one of the most effective pain relief creams currently available on the market today.

CEO Gregory Rotelli exclaimed: “ChiroRub 2000 is one of our first product launches and has been validated through a network of medical professionals. It is one step toward our goal of improving people’s lives through the use of non-addictive remedies that provide relief and are cost effective. This further reflects our continuing commitment to product development in conjunction with our medical professional advisors and customers.”

Last week LITH launched its beta ecommerce website, bioelife.net. The new site will allow wholesale customers, as well as consumers, to register, view and purchase all of BioELife’s current product offerings. This includes adult CBD gum drops, the Company’s highly concentrated topical 2,000 mg CBD intensive pain cream, premium pre-rolls and flower from its farm partner Hemp Heaven Farms. The Company’s corporate site will provide corporate background, investor relations, and information on current and upcoming products.

We have a Monster Pick Coming. Subscribe Right Now!

Currently trading at a $6.8 million market valuation LITH has little assets, no revenues and is debt free making this an excellent choice for a new CBD business. While the Company has entered the CBD space with a flurry of press the stock continues to trade among the most traded stocks in small caps regularly topping $500k daily in dollar volume which is very significant for an unknwon CBD Company with no sales and no operating history. While the momentum lasts this could be good but experienced investors know they are walking on thin ice when they are buying a pink sheet listed stock over $1. We will be updating on LITH when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with LITH.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in LITH either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.